Batroxobin

Batroxobin is a serine protease derived from the venom of Bothrops atrox. (From the Wikpedia article Batroxobin.)

Download PDF

Recent Publications on Batroxobin:
Influence of direct thrombin inhibitor argatroban on coagulation assays in healthy individuals, patients under oral anticoagulation therapy and patients with liver dysfunction. We assumed that argatroban, a direct thrombin inhibitor, has a strong...	18th July, 2008	Institut fur Klinische Chemie und Laboratoriumsdiagnostik,	Blood Coagul Fibrinolysis. 2008 Jun;19(4):288-93. DOI Direct Link
Effect of hemocoagulase for prevention of pulmonary hemorrhage in critical newborns on mechanical ventilation: a randomized controlled trial. OBJECTIVE: To investigate the role of hemocoagulase to prevent pulmonary...	11th July, 2008	Department of Pediatrics, Research Institute of Surgery and Daping	Indian Pediatr. 2008 Mar;45(3):199-202.
Immune complex-mediated glomerulonephritis is ameliorated by thrombin-activatable fibrinolysis inhibitor deficiency. The activity of plasmin plays a critical role in the development of...	10th July, 2008	Department of Immunology, Mie University Graduate School of Medicine,	Thromb Haemost. 2008 Jul;100(1):90-100.
Cleavage of factor XIII by human neutrophil elastase results in a novel active truncated form of factor XIII A subunit. The first step in the activation of plasma factor XIII (FXIII) is the...	28th June, 2008	University of Debrecen, Medical and Health Science Center, Clinical	Thromb Haemost. 2008 Apr;99(4):668-74.
GlycoWorkbench: a tool for the computer-assisted annotation of mass spectra of glycans. Mass spectrometry is the main analytical technique currently used to...	24th June, 2008	Division of Molecular Biosciences, Imperial College London, London SW72AZ,	J Proteome Res. 2008 Apr;7(4):1650-9. Epub 2008 Mar 1. DOI Direct Link
→View more research publications.

Batroxobin Patents:
US Patent No.	Title
6395889	Nucleic acid molecules encoding human protease homologs
6627215	Devices for improved wound management
6630139	Fibrinogenolytic proteases with thrombolytic and antihypertensive activities: medical application and novel process of expression and production
6682520	Tissue volume reduction
6699484	Fibrin sealants or adhesives comprising a hyaluronic acid derivative material
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Batroxobin scientists - we have details of around 42 individuals working on Batroxobin .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.